Table 2 Frequency of Use of Anti-Diabetic Medications
From: Resource use among patients with diabetes, diabetic neuropathy, or diabetes with depression
Anti-Diabetic Medications | Diabetes (N = 55.972) | Diabetic Neuropathy (N = 2,146) | Diabetes and Depression (N = 2,379) | P-Value | |||||
|---|---|---|---|---|---|---|---|---|---|
N | % | N | % | N | % | DM v DN | DM v DD | DN v DD | |
Sulfonylurea | |||||||||
   Glimepiried | 2,821 | 5.04 | 180 | 8.29 | 192 | 8.07 | * | * | 0.8823 |
   Glipizide | 9,034 | 16.14 | 458 | 21.34 | 554 | 23.29 | * | * | 0.1846 |
   Glyburide | 7,446 | 13.30 | 451 | 21.02 | 466 | 19.59 | * | * | 0.3454 |
   Any Sulfonylurea | 18,207 | 32.53 | 924 | 43.06 | 1,072 | 45.06 | * | * | 0.3253 |
Meglitinide | |||||||||
   Nateglinide | 222 | 0.40 | 19 | 0.89 | 6 | 0.25 | *** | 0.5252 | *** |
   Repaglinide | 863 | 1.54 | 63 | 2.94 | 1 | 2.27 | * | *** | 0.1790 |
   Any Meglitinide | 1,078 | 1.93 | 82 | 3.32 | 60 | 2.52 | * | 0.1059 | *** |
Biguanide | |||||||||
   Metformin HCL | 15,744 | 28.13 | 952 | 44.36 | 1,072 | 45.06 | * | * | 0.8625 |
Thiazolidinedione | |||||||||
   Pioglitazone HCL | 2,371 | 4.24 | 227 | 10.58 | 233 | 9.79 | * | * | 0.4238 |
   Rosiglitazone Maleate | 3,073 | 5.49 | 287 | 13.37 | 292 | 12.27 | * | * | 0.2650 |
   Any Thiazolidinedione | 5,283 | 9.44 | 491 | 22.88 | 494 | 20.77 | * | * | *** |
Alpha Glucose Inhibitor | |||||||||
   Acarbose | 256 | 0.46 | 13 | 0.61 | 18 | 0.76 | 0.5883 | 0.0939 | 0.7412 |
   Miglitol | 112 | 0.20 | 13 | 0.61 | 1 | 0.04 | ** | 0.2222 | * |
   Any Alpha Glucose Inhibitor | 363 | 0.65 | 26 | 1.21 | 19 | 0.80 | *** | 0.6553 | 0.2072 |
Insulin | |||||||||
   Insulin Glargine | 272 | 0.49 | 68 | 3.17 | 75 | 3.15 | * | * | 0.9976 |
   Insulin Lispro | 2,837 | 5.07 | 469 | 21.85 | 359 | 15.09 | * | * | * |
   Any Insulin | 2,940 | 5.25 | 493 | 22.97 | 381 | 16.02 | * | * | * |